sexta-feira, 29 de agosto de 2008

Novidades Semanais do Doctor's Guide

FDA Investigating Possible Link Between Ezetimibe/Simvastatin and Increased Cancer Risk
ROCKVILLE, Md -- August 21, 2008 -- The US Food and Drug Administration (FDA) is informing healthcare professionals that it is investigating a report from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of a possible association between the use of simvastatin/ezetimibe (Vytorin) and a potentially increased incidence of cancer. ...Full Story







Most read General Medicine news in the past 7 days

Papers and articles, pertaining to General Medicine, most read by your colleagues in the past 7 days

Nenhum comentário: